Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?
Reid F. Thompson(Oregon Health & Science University), Charles R. Thomas(Dartmouth–Hitchcock Medical Center), William D. Lindsay(Cohera Medical (United States)), Sanjay Aneja(Yale University), Barbara Agrimson(Oregon Health & Science University), Clifton D. Fuller(The University of Texas MD Anderson Cancer Center), Curtiland Deville(Johns Hopkins University), James B. Yu(Harvard University), Olivier Morin(University of California, San Francisco), Gilmer Valdés(University of California, San Francisco), Hugo J.W.L. Aerts(Harvard University), Colin M. Carpenter, Seth A. Rosenthal(The University of Texas MD Anderson Cancer Center)
Cited by 252
Related Papers
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation Therapy
|International Journal of Radiation Oncology*Biology*Physics|2010|664
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646
Artificial intelligence in radiation oncology
|Nature Reviews Clinical Oncology|2020|399
Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy
|Scientific Data|2018|325
Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer
|Journal of the American College of Cardiology|2019|270